Blood and Laboratory Solutions Licensed by German University
|
By LabMedica International staff writers Posted on 22 Apr 2009 |
A German University clinic has licensed a blood information system and laboratory information system for its blood center.
EdgeBlood is the leading Blood Center management system used in France. It is also used to process more than half the blood drawn in Germany as well as processing significant parts of the Austrian and Swiss blood supplies. EdgeBlood is used in Greece as well as five African countries. EdgeBlood has an easy-to-use Windows graphical user interface and contains all major functionality needed by a blood center from donor recruitment through product distribution.
EdgeLab has become the leading Laboratory Information Management System (LIMS) in Europe and is used in more than 150 licensed laboratories. EdgeLab is connected with more than 1,000 analyzers and interchanges data with all major hospital healthcare software packages. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. EdgeLab can be easily configured to meet the business needs of large, diverse, multisite hospital laboratories, as well as small, single site hospitals.
GLI (Alzey, Germany) is the German division of Global Med Technology's Inlog subsidiary. The two systems, EdgeBlood and EdgeLab, have been licensed by the University of Saarland Clinic Blood Center (Homburg, Germany) from GLI. The systems will be deployed on 25 workstations in the blood center and laboratory. Up to 50 remote users will access the Web result server EdgeNet. Five analyzers will be connected to EdgeLab, Inlog's Laboratory Information System. The blood center collects 30,000 whole blood donations per year.
"After detailed market research, the University Medical Center of Saarland has decided to install the LIS EdgeBlood/EdgeLab from the company, GLI. This decision was made because, among other reasons, the system can completely control the management of all essential services in transfusion medicine. Moreover, the software is already in use in the National German Red Cross Blood Donation Services. It has also been used successfully in comparable university facilities for many years. In view of the connection between pharmaceutical and clinical aspects of transfusion medicine, EdgeBlood and EdgeLab will create a center of excellence for the University Medical Center of Saarland," stated Prof. Dr. med. Hermann Eichler of the Institute of Clinical Hemostaseology and Transfusion Medicine Homburg/University Medical Center of Saarland.
Related Links:
GLI
University of Saarland Clinic Blood Center
EdgeBlood is the leading Blood Center management system used in France. It is also used to process more than half the blood drawn in Germany as well as processing significant parts of the Austrian and Swiss blood supplies. EdgeBlood is used in Greece as well as five African countries. EdgeBlood has an easy-to-use Windows graphical user interface and contains all major functionality needed by a blood center from donor recruitment through product distribution.
EdgeLab has become the leading Laboratory Information Management System (LIMS) in Europe and is used in more than 150 licensed laboratories. EdgeLab is connected with more than 1,000 analyzers and interchanges data with all major hospital healthcare software packages. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. EdgeLab can be easily configured to meet the business needs of large, diverse, multisite hospital laboratories, as well as small, single site hospitals.
GLI (Alzey, Germany) is the German division of Global Med Technology's Inlog subsidiary. The two systems, EdgeBlood and EdgeLab, have been licensed by the University of Saarland Clinic Blood Center (Homburg, Germany) from GLI. The systems will be deployed on 25 workstations in the blood center and laboratory. Up to 50 remote users will access the Web result server EdgeNet. Five analyzers will be connected to EdgeLab, Inlog's Laboratory Information System. The blood center collects 30,000 whole blood donations per year.
"After detailed market research, the University Medical Center of Saarland has decided to install the LIS EdgeBlood/EdgeLab from the company, GLI. This decision was made because, among other reasons, the system can completely control the management of all essential services in transfusion medicine. Moreover, the software is already in use in the National German Red Cross Blood Donation Services. It has also been used successfully in comparable university facilities for many years. In view of the connection between pharmaceutical and clinical aspects of transfusion medicine, EdgeBlood and EdgeLab will create a center of excellence for the University Medical Center of Saarland," stated Prof. Dr. med. Hermann Eichler of the Institute of Clinical Hemostaseology and Transfusion Medicine Homburg/University Medical Center of Saarland.
Related Links:
GLI
University of Saarland Clinic Blood Center
Latest Hematology News
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
- Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
- Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
- Advanced CBC-Derived Indices Integrated into Hematology Platforms
- Blood Test Enables Early Detection of Multiple Myeloma Relapse
- Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
- Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma
- Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
- Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
- New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
- Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








